eXoZymes Inc. Common Stock EXOZ Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 1.3×— | 2.5×— | 4.5×— | 6.2×— | —— | |
| Leverage | ||||||
| Debt-to-equity | 0.8×— | 0.4×— | 0.3×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $0.18-83.0% | $0.41-74.5% | $0.64+211% | $0.86+339% | $1.06— | |
| Valuation | ||||||
| Market capitalization | $76.8M-5.6% | —— | —— | —— | —— | |
| Price / book | 50.3×+39.0× | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do eXoZymes Inc. Common Stock's ratios come from?
- Every ratio is computed from eXoZymes Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
